The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.

Early access to AstraZeneca investigational medicinal products We recognise that there are circumstances where patients with serious or life-threatening diseases have exhausted all available therapeutic options and may not be eligible to enrol in one of our clinical trials.

Dec 14, 2020 · In cancer research, AstraZeneca focuses on four primary scientific platforms — immuno-oncology, tumor drivers and resistance, DNA damage response, and antibody-drug conjugates. The company makes...

AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

At AstraZeneca our industry-leading pipeline includes investigational therapies in various stages of clinical development - from approved medicines to earlier-stage molecules in clinical trials.

AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation areas. [108]

Dec 5, 2024 · AstraZeneca manufactures, markets and/or distributes more than 36 drugs in the United States. Medications listed here may also be marketed under different names in different …

We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the …

AstraZeneca's global website is intended for people seeking information on AstraZeneca's worldwide business. Click the 'Global site' link for the directory of country sites.

At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition.